Allergan Revenue, Profits - AGN Quarterly Income Statement

Add to My Stocks
$171.72 $1.46 (0.84%) AGN stock closing price Jun 18, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Allergan stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue decrease to $3.67B for 2018 Q1 impacts the AGN stock. Investors typically check year over year or quarter over quarter revenue growth. The operating expenses as shown in the Allergan profit and loss statement for 2018 Q1 total to $3.8B. This line item shows that the operating expenses has decreased compared with last year. Also check: Allergan assets and Allergan free cash flow.

View and download details of revenue and profits for Allergan for latest & last 40 quarters.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Allergan Revenues or Net Sales
Cost Of Goods Sold (COGS)522.8M580.9M586.5M550.2M450.4M145.3M462.2M441.5M811.8M-276M
Allergan Gross Profit
Research & Development Expense996.7M615.2M644.6M1.19B1.1B1.34B664.8M905.4M409.1M226.1M
Selling General & Admin Expense1.11B1.3B5.04B1.41B1.19B1.26B1.15B1.19B1.14B934.7M
Income Before Depreciation Depletion Amortization1.04B1.83B-2.24B855.5M830M718.39M1.34B1.15B1.44B108.09M
Depreciation Depletion Amortization1.7B1.92B1.78B1.76B1.74B1.64B1.61B1.63B1.59B1.29B
Non Operating Income-61.5M-56M-1.3B-116.9M-1.9B81.2M51.7M152.6M3.6M15.9M
Interest Expense250.6M263.3M265.2M277.4M289.7M292.7M324.3M345.8M332.8M341.3M
Allergan Pretax Income
Provision for Income Taxes-682.2M-3.92B-1.64B-581.2M-532.1M-1.08B-158.9M-258.2M-402M-252M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations-286.1M3.51B-4.02B-717.5M-2.56B-41.9M-381.9M-422.6M-81.7M-770.7M
Extraordinary Items & Discontinued Operations--385.3M-6.1M-8.4M-3.1M41.3M15.6B-79.1M337.4M139.8M
Allergan Profit/ Loss (Net Income)
Average Shares used to compute Diluted EPS334.6M351.6M333.5M335.2M335.1M356.8M392.7M395.6M394.8M394.2M
Average Shares used to compute Basic EPS334.6M331.3M333.5M335.2M335.1M356.8M392.7M395.6M394.8M394.2M
Income Before Nonrecurring Items1.31B1.71B1.47B1.44B1.2B1.46B1.37B1.4B1.27B1.42B
Income from Nonrecurring Items-1.59B1.8B-5.49B-2.15B-3.76B-1.5B-1.76B-1.82B-1.35B-2.19B
Allergan Earnings Per Share Basic Net
Allergan Earnings Per Share Diluted Net
EPS Diluted Before Nonrecurring Items3.744.864.154.023.353.903.323.353.043.41
Preferred Dividends Acc Pd-70.03M--------
Dividends Common244.13232.81--------
Dividend Per Share Common0.720.700.700.700.700.
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

The key things to look for in an income statement while doing Allergan stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A QoQ growth - See: Allergan revenue chart, implies that the company is growing. It has not been the case with Allergan. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-286.1M for AGN stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The AGN financials along with Allergan historical stock prices provide a lot of details about the firm.

Allergan Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
Dividend Yield